Menu

Blog

Legal insights and highlights in product liability, dangerous drugs, and mesothelioma and asbestos cases.


Example of 3 E-Cig MOD Vaporizers

Surgeon’s Case Report: Rise in Burns from Vape Battery Explosions

A case report in the May edition of the medical journal Burns notes that failing lithium-ion batteries are responsible for the uptick in new cases of battery explosion burns.  Batteries stored in e-cig or vape mod devices can suffer from a run-away chemical reaction and explode. The case report is titled “Canary in the coal mine—Initial… Read More

Posted in: All

FDA image

FDA requests Endo Pharmaceuticals pull Opana ER from the market

  The Food and Drug Administration (FDA) has requested Endo Pharmaceuticals pull Opana ER from the market. Opana ER is an extended-release opioid, or narcotic. The drug is heavily abused by patients and can lead to addictions, which can then lead to overdoses and death. The Center for Disease Control and Prevention (CDC) currently estimates… Read More

Posted in: All

Talc Orange Top Quarter Size

6th Talcum Powder Ovarian Cancer Trial Begins

(St Louis, Missouri) Last Friday a trial began in St. Louis for the families of three women who contracted ovarian cancer after use of talcum powder baby powder products. Johnson & Johnson and other companies marketed baby powder products containing talcum powder, despite knowing that baby powder increased their customer’s risk of ovarian cancer. This… Read More

Posted in: All

E-Cig Cropped

E-cig vape explosions in the news

Levin Simes has updated our list of e-cig vape explosions news stories. To catch up on all the news you can visit our page here: E-Cig Vape Explosions in the News You can also learn about the dangers of e-cig and vape batteries, the mechanisms at work when a battery overheats and explodes, recommendations to avoid injury, and… Read More

Posted in: All

Invokana increases risk of kidney damage and foot, toe and leg amputation

Invokana doubles amputation risk vs placebo

March 16, 2017: The FDA released a new communication today warnings of serious risks of Invokana – a prescription medicine for Type II Diabietes.  The FDA warned that Invokana poses an increased risk of foot and leg amputations, based on studies showing the risk of amputation of limbs doubling with Invokano use versus a placebo.… Read More

Posted in: All